Published in Public Health Rep on September 03, 2008
Cost-effectiveness of hepatitis B vaccination in adults with diagnosed diabetes. Diabetes Care (2012) 0.87
Economic evaluation of HBV vaccination: A systematic review of recent publications (2000-2013). Hum Vaccin Immunother (2016) 0.75
Markov models in medical decision making: a practical guide. Med Decis Making (1994) 8.14
Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med (2002) 6.20
Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep (2002) 5.75
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep (2006) 5.63
Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med (1986) 4.51
Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis (1985) 4.47
Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis. Ann Intern Med (2005) 2.68
Incidence of hepatitis B virus infection in the United States, 1976-1994: estimates from the National Health and Nutrition Examination Surveys. J Infect Dis (1998) 2.67
Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med (2001) 2.57
The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci (1993) 2.12
Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. J Infect Dis (2002) 2.06
Hepatitis B vaccination among high-risk adolescents and adults--San Diego, California, 1998-2001. MMWR Morb Mortal Wkly Rep (2002) 1.93
Screening for chronic hepatitis B and C virus infections in an urban sexually transmitted disease clinic: rationale for integrating services. Sex Transm Dis (2001) 1.81
Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology (1995) 1.76
Natural history and prognostic factors for chronic hepatitis type B. Gut (1991) 1.75
Surveillance for acute viral hepatitis--United States, 2005. MMWR Surveill Summ (2007) 1.62
United States life tables, 2002. Natl Vital Stat Rep (2004) 1.54
Recommendation of the Immunization Practices Advisory Committee (ACIP). Inactivated hepatitis B virus vaccine. MMWR Morb Mortal Wkly Rep (1982) 1.50
Integrating viral hepatitis prevention into STD clinics in Illinois (excluding Chicago), 1999-2005. Public Health Rep (2007) 1.46
Integrating viral hepatitis prevention services into an urban STD clinic: Denver, Colorado. Public Health Rep (2007) 1.44
Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology (1986) 1.38
Hepatitis B vaccination--United States, 1982-2002. MMWR Morb Mortal Wkly Rep (2002) 1.26
Public health departments providing sexually transmitted disease services. Fam Plann Perspect (1997) 1.23
Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine. Am J Med (1989) 1.22
The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma. J Infect Dis (1985) 1.20
Integrating hepatitis B prevention into sexually transmitted disease services: U.S. sexually transmitted disease program and clinic trends--1997 and 2001. Sex Transm Dis (2005) 1.07
Factors associated with receiving hepatitis B vaccination among high-risk adults in the United States: an analysis of the National Health Interview Survey, 2000. Fam Med (2004) 1.04
Hepatitis B vaccination in six STD clinics in the United States committed to integrating viral hepatitis prevention services. Public Health Rep (2007) 1.03
Hepatitis B vaccination in sexually transmitted disease (STD) clinics: a survey of STD programs. Sex Transm Dis (2001) 1.03
Results of immunisation with a recombinant yeast-derived hepatitis B vaccine. J Infect (1986) 1.02
The liver histology and frequency of clearance of the hepatitis B surface antigen (HBsAg) in chronic carriers. Am J Med Sci (1979) 0.99
Hepatitis B vaccination of inmates in correctional facilities--Texas, 2000-2002. MMWR Morb Mortal Wkly Rep (2004) 0.97
Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites. Am J Prev Med (2006) 0.96
Long-term follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Austria: a clinical and histologic evaluation of 242 cases. Hepatology (1987) 0.92
Vaccine preventable diseases and vaccination policy for indigenous populations. Epidemiol Rev (2006) 0.90
A model to estimate the potential economic benefits of measles eradication for the United States. Vaccine (1998) 0.83
Development of cirrhosis after chronic type B hepatitis: a clinicopathologic and follow-up study of 46 HBeAg-positive asymptomatic patients. Am J Gastroenterol (1991) 0.83
Cost-effectiveness of preimmunization hepatitis B screening in high-risk adolescents. Public Health Rep (2002) 0.78
Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: final results of the RNS System Pivotal trial. Epilepsia (2014) 2.60
West Nile virus economic impact, Louisiana, 2002. Emerg Infect Dis (2004) 1.83
Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza. PLoS Curr (2010) 1.57
Challenges in replicating interventions. J Adolesc Health (2006) 1.41
Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004. J Urban Health (2007) 1.21
Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States. Pediatrics (2007) 1.13
Integrating hepatitis B prevention into sexually transmitted disease services: U.S. sexually transmitted disease program and clinic trends--1997 and 2001. Sex Transm Dis (2005) 1.07
Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users. Drug Alcohol Depend (2007) 1.05
Hepatitis B vaccination in six STD clinics in the United States committed to integrating viral hepatitis prevention services. Public Health Rep (2007) 1.03
SARS surveillance during emergency public health response, United States, March-July 2003. Emerg Infect Dis (2004) 1.03
The costs and impacts of testing for hepatitis C virus antibody in public STD clinics. Public Health Rep (2007) 1.01
Hepatitis B vaccination coverage among high-risk adults 18-49 years, U.S., 2009. Vaccine (2011) 0.98
Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5 years after breast cancer diagnosis. J Clin Oncol (2010) 0.98
The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity. Pediatrics (2007) 0.97
Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites. Am J Prev Med (2006) 0.96
Hepatitis C prevention programs: assessment of local health department capacity. J Public Health Manag Pract (2002) 0.92
Poliomyelitis outbreaks in Angola genetically linked to India: risk factors and implications for prevention of outbreaks due to wild poliovirus importations. Vaccine (2011) 0.91
Recommendations for prevention, screening, and diagnosis of HBV and HCV infections. J Fam Pract (2010) 0.87
Prospective cost-benefit analysis of a two-dimensional barcode for vaccine production, clinical documentation, and public health reporting and tracking. Vaccine (2013) 0.86
Vaccinating adolescents in high-risk settings: lessons learned from experiences with hepatitis B vaccine. Pediatrics (2008) 0.85
Hepatitis A seroprevalence and risk factors among homeless adults in San Francisco: should homelessness be included in the risk-based strategy for vaccination? Public Health Rep (2009) 0.85
Trends in compliance with two-dose influenza vaccine recommendations among children aged 6 months through 8 years. Vaccine (2013) 0.83
Pandemic influenza and pregnancy revisited: lessons learned from 2009 pandemic influenza A (H1N1). Am J Obstet Gynecol (2011) 0.82
The association between use of non-injection drug implements and hepatitis C virus antibody status in homeless and marginally housed persons in San Francisco. J Public Health (Oxf) (2012) 0.80
Impact of hepatitis A vaccination on health care utilization in the United States, 1996-2004. Vaccine (2007) 0.78
Anticoagulant options in atrial fibrillation: When new treatments become standard practice. Nurse Pract (2017) 0.75
1972: SPONTANEOUS TUMOR LYSIS SYNDROME FROM A SOLITARY METASTATIC CNS NONSEMINOMATOUS GERM CELL TUMOR. Crit Care Med (2016) 0.75
Hepatitis B in women: domestically and internationally. Emerg Infect Dis (2004) 0.75